STERIS plc (STE) rides on the robust performance of its Healthcare business.The company also benefits from the strong rebound prospects for its Applied Sterilization Technologies (“AST”) segment.Meanwhile, headwinds such as foreign currency risks and macroeconomic challenges are concerning.Year to date, shares of this Zacks Rank #3 (Hold) company have risen 10.6% compared with the industry’s 10% growth and the S&P 500’s 18.4% increase.The renowned provider of infection prevention and other procedural produc ...